Michel Alexander Steiner

8PUBLICATIONS
13CO-AUTHORS
Medical biochemistry - inorganic elements and compoundsMolecular targetsProteins and peptidesAnimal neurobiologySensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Impact of Sinbaglustat on Neurons of the Medial Nucleus of the Trapezoid Body in a Murine Model of Human GM1-Gangliosidosis.

Lorna Jubran, Rouven Wannemacher, Wolfgang Baumgärtner

|Apr 01, 2025
Antiseizure potential of the triple T-type calcium channel blocker ACT-709478 (apinocaltamide) in rodent models.

Melanie Kessler, Hélène Roellinger, Corinne Roucard

|Mar 15, 2024
Matters arising: In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.

Michel Alexander Steiner

|Mar 08, 2024
Evaluating the efficacy of the selective orexin 1 receptor antagonist nivasorexant in an animal model of binge-eating disorder.

Michel Alexander Steiner, Luca Botticelli, Giorgio Bergamini

|Feb 08, 2024
Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials.

Jodi T Williams, Martin H Bolli, Christine Brotschi

|Feb 08, 2024
Selective orexin 1 receptor antagonism does not affect effort-based responding for sucrose reward in rats.

Giorgio Bergamini, Sean Durkin, Michel Alexander Steiner

Pageof 2

Frequent Collaborators

1 joint publications

Jodi T Williams

1 joint publications

Martin H Bolli

1 joint publications

Christine Brotschi

1 joint publications

Luca Botticelli